Granite Bio (Series A and Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- April 29, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $100,000,000
Company Info
- Founders
- Patrick Loustau, Dominik Hartl, Gijs van den Brink, Eliot Forster
- Company Description
- Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
- Market
- Immunology
- Location
- Basel, Switzerland
- Coinvestors
- Versant Ventures, Novartis Venture Fund, Forbion, Sanofi Ventures